CD8A and ovarian cancer: Moreover, it helps to explain the increased number of tumour-infiltrating CD3+ and CD8+ lymphocytes reported in BRCA-mutated human ovarian cancers compared to BRCA non-mutated tumours [32], which was well reproduced in our model (Fig. 3e).